Report Detail
COVID-19 Impact on Global Pirfenidone Market Insights, Forecast to 2026
- RnM3987569 |
- 04 June, 2020 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Pirfenidone market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pirfenidone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pirfenidone market is segmented into
Tablet
Capsule
Other
Segment by Application, the Pirfenidone market is segmented into
Mild Idiopathic Pulmonary Fibrosis
Moderate Idiopathic Pulmonary Fibrosis
Other
Regional and Country-level Analysis
The Pirfenidone market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pirfenidone market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pirfenidone Market Share Analysis
Pirfenidone market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pirfenidone business, the date to enter into the Pirfenidone market, Pirfenidone product introduction, recent developments, etc.
The major vendors covered:
Genentech (Roche)
Shionogi
GNI Group
Beijing Continent
Cipla
Lupin Ltd
Zydus Cadila
Glenmark Pharmaceuticals
Koye Pharmaceuticals
MSN Laboratories
Wockhardt
Incepta Pharmaceuticals
Unimed Unihealth
1 Study Coverage
- 1.1 Pirfenidone Product Introduction
- 1.2 Market Segments
- 1.3 Key Pirfenidone Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Pirfenidone Market Size Growth Rate by Type
- 1.4.2 Tablet
- 1.4.3 Capsule
- 1.4.4 Other
- 1.5 Market by Application
- 1.5.1 Global Pirfenidone Market Size Growth Rate by Application
- 1.5.2 Mild Idiopathic Pulmonary Fibrosis
- 1.5.3 Moderate Idiopathic Pulmonary Fibrosis
- 1.5.4 Other
- 1.6 Coronavirus Disease 2019 (Covid-19): Pirfenidone Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Pirfenidone Industry
- 1.6.1.1 Pirfenidone Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Pirfenidone Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Pirfenidone Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Pirfenidone Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Pirfenidone Market Size Estimates and Forecasts
- 2.1.1 Global Pirfenidone Revenue 2015-2026
- 2.1.2 Global Pirfenidone Sales 2015-2026
- 2.2 Pirfenidone Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Pirfenidone Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Pirfenidone Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pirfenidone Competitor Landscape by Players
- 3.1 Pirfenidone Sales by Manufacturers
- 3.1.1 Pirfenidone Sales by Manufacturers (2015-2020)
- 3.1.2 Pirfenidone Sales Market Share by Manufacturers (2015-2020)
- 3.2 Pirfenidone Revenue by Manufacturers
- 3.2.1 Pirfenidone Revenue by Manufacturers (2015-2020)
- 3.2.2 Pirfenidone Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Pirfenidone Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Pirfenidone Revenue in 2019
- 3.2.5 Global Pirfenidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Pirfenidone Price by Manufacturers
- 3.4 Pirfenidone Manufacturing Base Distribution, Product Types
- 3.4.1 Pirfenidone Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Pirfenidone Product Type
- 3.4.3 Date of International Manufacturers Enter into Pirfenidone Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Pirfenidone Market Size by Type (2015-2020)
- 4.1.1 Global Pirfenidone Sales by Type (2015-2020)
- 4.1.2 Global Pirfenidone Revenue by Type (2015-2020)
- 4.1.3 Pirfenidone Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Pirfenidone Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Pirfenidone Sales Forecast by Type (2021-2026)
- 4.2.2 Global Pirfenidone Revenue Forecast by Type (2021-2026)
- 4.2.3 Pirfenidone Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Pirfenidone Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Pirfenidone Market Size by Application (2015-2020)
- 5.1.1 Global Pirfenidone Sales by Application (2015-2020)
- 5.1.2 Global Pirfenidone Revenue by Application (2015-2020)
- 5.1.3 Pirfenidone Price by Application (2015-2020)
- 5.2 Pirfenidone Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Pirfenidone Sales Forecast by Application (2021-2026)
- 5.2.2 Global Pirfenidone Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Pirfenidone Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Pirfenidone by Country
- 6.1.1 North America Pirfenidone Sales by Country
- 6.1.2 North America Pirfenidone Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Pirfenidone Market Facts & Figures by Type
- 6.3 North America Pirfenidone Market Facts & Figures by Application
7 Europe
- 7.1 Europe Pirfenidone by Country
- 7.1.1 Europe Pirfenidone Sales by Country
- 7.1.2 Europe Pirfenidone Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Pirfenidone Market Facts & Figures by Type
- 7.3 Europe Pirfenidone Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Pirfenidone by Region
- 8.1.1 Asia Pacific Pirfenidone Sales by Region
- 8.1.2 Asia Pacific Pirfenidone Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Pirfenidone Market Facts & Figures by Type
- 8.3 Asia Pacific Pirfenidone Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Pirfenidone by Country
- 9.1.1 Latin America Pirfenidone Sales by Country
- 9.1.2 Latin America Pirfenidone Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Pirfenidone Market Facts & Figures by Type
- 9.3 Central & South America Pirfenidone Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Pirfenidone by Country
- 10.1.1 Middle East and Africa Pirfenidone Sales by Country
- 10.1.2 Middle East and Africa Pirfenidone Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Pirfenidone Market Facts & Figures by Type
- 10.3 Middle East and Africa Pirfenidone Market Facts & Figures by Application
11 Company Profiles
- 11.1 Genentech (Roche)
- 11.1.1 Genentech (Roche) Corporation Information
- 11.1.2 Genentech (Roche) Description, Business Overview and Total Revenue
- 11.1.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Genentech (Roche) Pirfenidone Products Offered
- 11.1.5 Genentech (Roche) Recent Development
- 11.2 Shionogi
- 11.2.1 Shionogi Corporation Information
- 11.2.2 Shionogi Description, Business Overview and Total Revenue
- 11.2.3 Shionogi Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Shionogi Pirfenidone Products Offered
- 11.2.5 Shionogi Recent Development
- 11.3 GNI Group
- 11.3.1 GNI Group Corporation Information
- 11.3.2 GNI Group Description, Business Overview and Total Revenue
- 11.3.3 GNI Group Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 GNI Group Pirfenidone Products Offered
- 11.3.5 GNI Group Recent Development
- 11.4 Beijing Continent
- 11.4.1 Beijing Continent Corporation Information
- 11.4.2 Beijing Continent Description, Business Overview and Total Revenue
- 11.4.3 Beijing Continent Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Beijing Continent Pirfenidone Products Offered
- 11.4.5 Beijing Continent Recent Development
- 11.5 Cipla
- 11.5.1 Cipla Corporation Information
- 11.5.2 Cipla Description, Business Overview and Total Revenue
- 11.5.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Cipla Pirfenidone Products Offered
- 11.5.5 Cipla Recent Development
- 11.6 Lupin Ltd
- 11.6.1 Lupin Ltd Corporation Information
- 11.6.2 Lupin Ltd Description, Business Overview and Total Revenue
- 11.6.3 Lupin Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Lupin Ltd Pirfenidone Products Offered
- 11.6.5 Lupin Ltd Recent Development
- 11.7 Zydus Cadila
- 11.7.1 Zydus Cadila Corporation Information
- 11.7.2 Zydus Cadila Description, Business Overview and Total Revenue
- 11.7.3 Zydus Cadila Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Zydus Cadila Pirfenidone Products Offered
- 11.7.5 Zydus Cadila Recent Development
- 11.8 Glenmark Pharmaceuticals
- 11.8.1 Glenmark Pharmaceuticals Corporation Information
- 11.8.2 Glenmark Pharmaceuticals Description, Business Overview and Total Revenue
- 11.8.3 Glenmark Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Glenmark Pharmaceuticals Pirfenidone Products Offered
- 11.8.5 Glenmark Pharmaceuticals Recent Development
- 11.9 Koye Pharmaceuticals
- 11.9.1 Koye Pharmaceuticals Corporation Information
- 11.9.2 Koye Pharmaceuticals Description, Business Overview and Total Revenue
- 11.9.3 Koye Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Koye Pharmaceuticals Pirfenidone Products Offered
- 11.9.5 Koye Pharmaceuticals Recent Development
- 11.10 MSN Laboratories
- 11.10.1 MSN Laboratories Corporation Information
- 11.10.2 MSN Laboratories Description, Business Overview and Total Revenue
- 11.10.3 MSN Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 MSN Laboratories Pirfenidone Products Offered
- 11.10.5 MSN Laboratories Recent Development
- 11.1 Genentech (Roche)
- 11.1.1 Genentech (Roche) Corporation Information
- 11.1.2 Genentech (Roche) Description, Business Overview and Total Revenue
- 11.1.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Genentech (Roche) Pirfenidone Products Offered
- 11.1.5 Genentech (Roche) Recent Development
- 11.12 Incepta Pharmaceuticals
- 11.12.1 Incepta Pharmaceuticals Corporation Information
- 11.12.2 Incepta Pharmaceuticals Description, Business Overview and Total Revenue
- 11.12.3 Incepta Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Incepta Pharmaceuticals Products Offered
- 11.12.5 Incepta Pharmaceuticals Recent Development
- 11.13 Unimed Unihealth
- 11.13.1 Unimed Unihealth Corporation Information
- 11.13.2 Unimed Unihealth Description, Business Overview and Total Revenue
- 11.13.3 Unimed Unihealth Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Unimed Unihealth Products Offered
- 11.13.5 Unimed Unihealth Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Pirfenidone Market Estimates and Projections by Region
- 12.1.1 Global Pirfenidone Sales Forecast by Regions 2021-2026
- 12.1.2 Global Pirfenidone Revenue Forecast by Regions 2021-2026
- 12.2 North America Pirfenidone Market Size Forecast (2021-2026)
- 12.2.1 North America: Pirfenidone Sales Forecast (2021-2026)
- 12.2.2 North America: Pirfenidone Revenue Forecast (2021-2026)
- 12.2.3 North America: Pirfenidone Market Size Forecast by Country (2021-2026)
- 12.3 Europe Pirfenidone Market Size Forecast (2021-2026)
- 12.3.1 Europe: Pirfenidone Sales Forecast (2021-2026)
- 12.3.2 Europe: Pirfenidone Revenue Forecast (2021-2026)
- 12.3.3 Europe: Pirfenidone Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Pirfenidone Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Pirfenidone Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Pirfenidone Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Pirfenidone Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Pirfenidone Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Pirfenidone Sales Forecast (2021-2026)
- 12.5.2 Latin America: Pirfenidone Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Pirfenidone Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Pirfenidone Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Pirfenidone Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Pirfenidone Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Pirfenidone Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Pirfenidone Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Pirfenidone Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Pirfenidone. Industry analysis & Market Report on COVID-19 Impact on Global Pirfenidone is a syndicated market report, published as COVID-19 Impact on Global Pirfenidone Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Pirfenidone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
